vs
Side-by-side financial comparison of Abbott Laboratories (ABT) and Capital One (COF). Click either name above to swap in a different company.
Capital One is the larger business by last-quarter revenue ($15.2B vs $11.5B, roughly 1.3× Abbott Laboratories). Abbott Laboratories runs the higher net margin — 15.5% vs 14.3%, a 1.2% gap on every dollar of revenue. On growth, Abbott Laboratories posted the faster year-over-year revenue change (4.4% vs -2.3%). Over the past eight quarters, Capital One's revenue compounded faster (26.6% CAGR vs 7.2%).
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
Capital One Financial Corporation is an American bank holding company founded on July 21, 1994, and specializing in credit cards, auto loans, banking, and savings accounts, headquartered in Tysons, Virginia, with operations primarily in the United States. It is the sixth-largest bank in the United States by total assets as of June 30, 2025, the third-largest issuer of Visa and Mastercard credit cards, and one of the largest car finance companies in the United States.
ABT vs COF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $11.5B | $15.2B |
| Net Profit | $1.8B | $2.2B |
| Gross Margin | 57.0% | — |
| Operating Margin | 19.6% | — |
| Net Margin | 15.5% | 14.3% |
| Revenue YoY | 4.4% | -2.3% |
| Net Profit YoY | -80.8% | 1.9% |
| EPS (diluted) | $1.01 | $3.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $15.2B | ||
| Q4 25 | $11.5B | $15.6B | ||
| Q3 25 | $11.4B | $15.4B | ||
| Q2 25 | $11.1B | $12.5B | ||
| Q1 25 | $10.4B | $10.0B | ||
| Q4 24 | $11.0B | $10.2B | ||
| Q3 24 | $10.6B | $10.0B | ||
| Q2 24 | $10.4B | $9.5B |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.8B | $2.1B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.8B | $-4.3B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $9.2B | $1.1B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.3B | $597.0M |
| Q1 26 | — | — | ||
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 55.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 19.6% | 85.8% | ||
| Q3 25 | 18.1% | 28.5% | ||
| Q2 25 | 18.4% | -47.5% | ||
| Q1 25 | 16.3% | 17.3% | ||
| Q4 24 | 17.4% | 14.3% | ||
| Q3 24 | 17.5% | 22.1% | ||
| Q2 24 | 16.1% | 6.8% |
| Q1 26 | — | 14.3% | ||
| Q4 25 | 15.5% | 87.2% | ||
| Q3 25 | 14.5% | 20.8% | ||
| Q2 25 | 16.0% | -34.2% | ||
| Q1 25 | 12.8% | 14.0% | ||
| Q4 24 | 84.1% | 10.8% | ||
| Q3 24 | 15.5% | 17.7% | ||
| Q2 24 | 12.5% | 6.3% |
| Q1 26 | — | $3.34 | ||
| Q4 25 | $1.01 | $4.33 | ||
| Q3 25 | $0.94 | $4.83 | ||
| Q2 25 | $1.01 | $-8.58 | ||
| Q1 25 | $0.76 | $3.45 | ||
| Q4 24 | $5.26 | $2.67 | ||
| Q3 24 | $0.94 | $4.41 | ||
| Q2 24 | $0.74 | $1.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.9B | — |
| Total DebtLower is stronger | $12.9B | — |
| Stockholders' EquityBook value | $52.1B | $112.3B |
| Total Assets | $86.7B | $682.9B |
| Debt / EquityLower = less leverage | 0.25× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.9B | — | ||
| Q3 25 | $7.7B | — | ||
| Q2 25 | $7.3B | — | ||
| Q1 25 | $6.8B | — | ||
| Q4 24 | $8.0B | — | ||
| Q3 24 | $7.8B | — | ||
| Q2 24 | $7.2B | — |
| Q1 26 | — | — | ||
| Q4 25 | $12.9B | $49.9B | ||
| Q3 25 | — | $50.9B | ||
| Q2 25 | — | $51.9B | ||
| Q1 25 | — | $41.2B | ||
| Q4 24 | $14.1B | $45.0B | ||
| Q3 24 | — | $48.8B | ||
| Q2 24 | — | $47.2B |
| Q1 26 | — | $112.3B | ||
| Q4 25 | $52.1B | $113.6B | ||
| Q3 25 | $51.0B | $113.8B | ||
| Q2 25 | $50.6B | $111.0B | ||
| Q1 25 | $48.8B | $63.5B | ||
| Q4 24 | $47.7B | $60.8B | ||
| Q3 24 | $39.8B | $62.9B | ||
| Q2 24 | $39.3B | $58.0B |
| Q1 26 | — | $682.9B | ||
| Q4 25 | $86.7B | $669.0B | ||
| Q3 25 | $84.2B | $661.9B | ||
| Q2 25 | $84.0B | $659.0B | ||
| Q1 25 | $81.4B | $493.6B | ||
| Q4 24 | $81.4B | $490.1B | ||
| Q3 24 | $74.4B | $486.4B | ||
| Q2 24 | $73.0B | $480.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.25× | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | 0.30× | 0.74× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.3B | — |
| Free Cash FlowOCF − Capex | $2.6B | — |
| FCF MarginFCF / Revenue | 22.9% | — |
| Capex IntensityCapex / Revenue | 6.0% | — |
| Cash ConversionOCF / Net Profit | 1.87× | — |
| TTM Free Cash FlowTrailing 4 quarters | $7.4B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.3B | $27.7B | ||
| Q3 25 | $2.8B | $9.2B | ||
| Q2 25 | $2.0B | $6.1B | ||
| Q1 25 | $1.4B | $4.7B | ||
| Q4 24 | $2.9B | $18.2B | ||
| Q3 24 | $2.7B | $6.5B | ||
| Q2 24 | $2.0B | $6.2B |
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $26.1B | ||
| Q3 25 | $2.3B | $8.8B | ||
| Q2 25 | $1.5B | $5.7B | ||
| Q1 25 | $933.0M | $4.3B | ||
| Q4 24 | $2.1B | $17.0B | ||
| Q3 24 | $2.1B | $6.1B | ||
| Q2 24 | $1.4B | $6.0B |
| Q1 26 | — | — | ||
| Q4 25 | 22.9% | 167.7% | ||
| Q3 25 | 20.2% | 57.1% | ||
| Q2 25 | 13.9% | 45.4% | ||
| Q1 25 | 9.0% | 43.2% | ||
| Q4 24 | 19.6% | 166.4% | ||
| Q3 24 | 20.2% | 61.4% | ||
| Q2 24 | 13.8% | 62.6% |
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 10.1% | ||
| Q3 25 | 4.4% | 2.5% | ||
| Q2 25 | 4.5% | 3.2% | ||
| Q1 25 | 4.7% | 3.5% | ||
| Q4 24 | 6.6% | 11.8% | ||
| Q3 24 | 5.2% | 3.1% | ||
| Q2 24 | 5.1% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 1.87× | 12.99× | ||
| Q3 25 | 1.70× | 2.87× | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 1.07× | 3.32× | ||
| Q4 24 | 0.31× | 16.57× | ||
| Q3 24 | 1.64× | 3.63× | ||
| Q2 24 | 1.51× | 10.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
